Capabilities

Initial Public Offering

MacroGenics, Inc.
2013

Our attorneys represented MacroGenics, Inc., a biopharmaceutical company, in its initial public offering of 5.75 million shares of common stock at a public offering price of $16.00 per share, before underwriting discounts. Fierce Biotech included the transaction in its ranking of "The top 10 biotech IPOs of 2013".

Email Disclaimer